Home > Products > intermedia > (5-Bromo-2-Chlorophenyl)(4-Ethoxyphenyl)Methanone
(5-Bromo-2-Chlorophenyl)(4-Ethoxyphenyl)Methanone
  • (5-Bromo-2-Chlorophenyl)(4-Ethoxyphenyl)Methanone(5-Bromo-2-Chlorophenyl)(4-Ethoxyphenyl)Methanone

(5-Bromo-2-Chlorophenyl)(4-Ethoxyphenyl)Methanone

Product Name:(5-Bromo-2-Chlorophenyl)(4-Ethoxyphenyl)MethanoneCAS NO:461432-22-4
Formulae hypotheticae: C15H12BrClO2
Formula Pondus: 339.61
Usu: Dapagliflozin Intermediates​

Mitte Inquisitionem

depictio producti

(5-Bromo-2-Chlorophenyl)(4-Ethoxyphenyl)Methanone

CAS NO:461432-22-4

Usu: Dapagliflozin intermedia

Nomen chemicum (5-Bromo-2-chlorophenyl)(4-ethoxyphenyl)methanone
CAS Number 461432-22-4
Formulae hypotheticae Câ‚ â‚…Hâ‚ â‚‚BrClOâ‚‚
M. Pondus 339.61
Categoria Investigationes Instrumentorum; Biologiae hypotheticae; Enzyme Activators et Inhibitores;
Applications (5-Bromo-2-chlorophenyl)(4-ethoxyphenyl) methanon media est usus in meliore synthesi Dapagliflozin, nova selectiva sodium-glucosi co-portatoris II (SGLT2) inhibitoris.
Divisio substantiae vel mixtionis;
GHS Classificationis ad normam 29 CFR 1910 (OSHA HCS) Nulla notitia.
2.2. GHSLabelelements,includingprecautionarystatements:
Nulla nota aleae.
Pertractatio et repono
Cautiones pro tuto tractando: Fuge contactum cum cute et oculis. Fuge inhalationem vaporis vel nebulae. Ab ignitionis fontibus abstinete - Non fumigans. Cave ne ædificare electro-
statarium crimen. For cautiones see section 2.2.
Conditiones repono pro tuto, inter quaslibet incompatibilitates: Continens arcte clausus in sicco et bene ventilato
locum. Vasa quae aperiuntur, diligenter aperiri debent et recti conservari
ultrices.
x


Hot Tags: (5-Bromo-2-Chlorophenyl)(4-Ethoxyphenyl) Methanone, China, Suppliers, Fabrica, Factory

Product Tag

Related Categoria

Mitte Inquisitionem

Libenter placet, ut inquisitionem tuam in forma infra exhibeas. Respondebimus tibi in 24 horis.
We use cookies to offer you a better browsing experience, analyze site traffic and personalize content. By using this site, you agree to our use of cookies. Privacy Policy
Reject Accept